05.11.16
Galderma Laboratories, L.P. is expanding its current North American headquarters. The project, which will be completed in first quarter 2017, will add 100,000-square-feet to the current 170,000-square-foot campus. The $22 million R&D, training and office building will also add up to 350 new positions to the company over the next few years, increasing home office employees to more than 600.
Under the umbrella of Nestlé Skin Health, Galderma has lately been experiencing a tremendous amount of growth following the launch of nine products in the past 20 months, including Cetaphil Men and Baby lines as well as prescription products like Soolantra Cream and aesthetic treatments like Restylane Silk and Restylane Lyft.
"This expansion shows Galderma's commitment to both skin health innovation and the Fort Worth community," said Miles Harrison, general manager and president of Galderma North America. "It's a game-changer in that it will allow us to double the number of staff at our North American headquarters, increase our talent and concentrate on our one and only focus: providing for skin health needs at every stage of life."
Under the umbrella of Nestlé Skin Health, Galderma has lately been experiencing a tremendous amount of growth following the launch of nine products in the past 20 months, including Cetaphil Men and Baby lines as well as prescription products like Soolantra Cream and aesthetic treatments like Restylane Silk and Restylane Lyft.
"This expansion shows Galderma's commitment to both skin health innovation and the Fort Worth community," said Miles Harrison, general manager and president of Galderma North America. "It's a game-changer in that it will allow us to double the number of staff at our North American headquarters, increase our talent and concentrate on our one and only focus: providing for skin health needs at every stage of life."
